Research in our lab focuses on drug-resistance management in malaria and human influenza epidemiology, seroepidemiology, and evolution. We also actively work in recombination detection and reconstruction of recombination histories and in several other areas of evolutionary and social epidemiology. Our next goal is to perform health-economic analyses to determine if deploying multiple first-line therapies is an economically feasible strategy.

More information on the Boni Laboratory is available at mol.ax.